BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21928708)

  • 1. UV derivative spectrophotometric and RP-HPLC methods for determination of imidapril hydrochloride in tablets and for its stability assessment in solid state.
    Stanisz B; Regulska K; Kolasa K
    Acta Pol Pharm; 2011; 68(5):645-51. PubMed ID: 21928708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of uv derivative spectrophotometric method for determination of benazepril hydrochloride in tablets and evaluation of its stability.
    Stanisz B; Paszun S; Leśniak M
    Acta Pol Pharm; 2009; 66(4):343-9. PubMed ID: 19702164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of degradation of imidapril hydrochloride in finished dosage formulations.
    Stanisz B; Regulska K
    Acta Pol Pharm; 2013; 70(4):737-42. PubMed ID: 23923397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First order derivative spectrophotometric and HPLC methods for determination of moexipril hydrochloride in the pure form, pharmeceutical formulations and evaluation of its stability.
    Stanisz B; Regulska K; Ratajczak T
    Acta Pol Pharm; 2012; 69(3):389-95. PubMed ID: 22594252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the applicability of differential spectroscopic method for the determination of lisinopril in tablets and for the evaluation of its stability.
    Stanisz B
    Acta Pol Pharm; 2004; 61(5):327-34. PubMed ID: 15747688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and simple stability indicating HPLC method for the determination of cilazapril in pure substance and pharmaceutical formulation in comparison with classic and derivative spectrophotometric methods.
    Paszun SK; Stanisz B; Pawłowski W
    Acta Pol Pharm; 2012; 69(2):193-201. PubMed ID: 22568033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods.
    Skibiński R; Komsta Ł; Hopkała H; Suchodolska I
    Anal Chim Acta; 2007 May; 590(2):195-202. PubMed ID: 17448345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isocratic RP-HPLC method for rutin determination in solid oral dosage forms.
    Kuntić V; Pejić N; Ivković B; Vujić Z; Ilić K; Mićić S; Vukojević V
    J Pharm Biomed Anal; 2007 Jan; 43(2):718-21. PubMed ID: 16920326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated liquid chromatographic determination of a novel ACE inhibitor in the presence of its hydrolytic and oxidative degradation products as per ICH guidelines.
    Hegazy MA; Eissa MS; Abd El-Sattar OI; Abd El-Kawy MM
    Talanta; 2014 Feb; 119():170-7. PubMed ID: 24401400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability-indicating methods for the determination of piretanide in presence of the alkaline induced degradates.
    Youssef NF
    J Pharm Biomed Anal; 2005 Oct; 39(5):871-6. PubMed ID: 16223647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of RP-HPLC method for the analysis of metformin.
    Arayne MS; Sultana N; Zuberi MH
    Pak J Pharm Sci; 2006 Jul; 19(3):231-5. PubMed ID: 16935831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC.
    Arayne MS; Sultana N; Siddiqui FA
    Pak J Pharm Sci; 2006 Oct; 19(4):326-9. PubMed ID: 17105713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability-indicating methods for determination of vincamine in presence of its degradation product.
    Shehata MA; El Sayed MA; El Tarras MF; El Bardicy MG
    J Pharm Biomed Anal; 2005 Jun; 38(1):72-8. PubMed ID: 15907622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a HPLC method for the determination of cetirizine in pharmaceutical dosage forms.
    Paw B; Misztal G; Hopkała H; Drozd J
    Pharmazie; 2002 May; 57(5):313-5. PubMed ID: 12061254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
    de Oliveira AM; Löwen TC; Cabral LM; dos Santos EM; Rodrigues CR; Castro HC; dos Santos TC
    J Pharm Biomed Anal; 2005 Jul; 38(4):751-6. PubMed ID: 15967304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of RP-HPLC method to determine letrozole in different pharmaceutical formulations and its application to studies of drug release from nanoparticles.
    Mondal N; Pal TK; Ghosal SK
    Acta Pol Pharm; 2009; 66(1):11-7. PubMed ID: 19226963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validated stability-indicating HPLC method for the determination of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) and its degradation products.
    Hadad GM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):695-703. PubMed ID: 18403161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
    Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
    Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.
    Oliveira DC; Weigch A; Rolim CM
    Pharmazie; 2007 Feb; 62(2):96-100. PubMed ID: 17341026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.